FDA MedWatch - Argatroban Injection 50 mg/50 mL (1 mg/mL): Recall - Potential for Visible Particulates

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

 



Title: FDA MedWatch - Argatroban Injection 50 mg/50 mL (1 mg/mL): Recall - Potential for Visible Particulates
MedWatch logoMedWatch - The FDA Safety Information and Adverse Event Reporting Program

Argatroban Injection 50 mg/50 mL (1 mg/mL): Recall - Potential for Visible Particulates

AUDIENCE: Pharmacy, Hematology

ISSUE: Eagle Pharmaceuticals Inc., supplier to The Medicines Company, issued a voluntary recall of all four (4) lots of Argatroban Injection, 50 mg per 50 mL from the market due to a potential for visible particulates. The risk of using an injectable product with particulates includes embolization/infarction to organs and potential organ complications.

BACKGROUND: During an investigation, a visible particulate was discovered in a stability sample in one of the distributed lots. This discovery prompted a re-inspection of undistributed lots at the manufacturing site. Upon this re-inspection, a small number of visible particulates were discovered in several vials. The affected products include: NDC# 42367-203-07 (single unit), NDC# 42367-203-84 (10 pack)

RECOMMENDATION: Eagle Pharmaceuticals Inc. directed The Medicines Company (“MDCO”) to arrange for the return of the affected product lots from all services and facilities. See the Press Release for a listing of affected lots.

Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

Read the MedWatch safety alert, including a link to the firm Press Release, at:

http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm297100.htm


This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery

[Index of Archives]     [CDC News]     [NIH News]     [USDA News]     [Steve's Art]     [Camping in Yosemite]     [PhotoForum]     [SB Lupus]     [STB]

  Powered by Linux